Skip to main content
Top
Published in: BMC Ophthalmology 1/2016

Open Access 01-12-2016 | Research article

Incidence of and risk factors for glaucoma in lost-to-follow-up normal-tension glaucoma suspect patients

Authors: Jong Hoon Lim, Jun Sang Park, So Yeon Lee, Young Jae Hong

Published in: BMC Ophthalmology | Issue 1/2016

Login to get access

Abstract

Background

To investigate the incidence and risk factors of glaucoma in normal-tension glaucoma (NTG) suspect patients who had been lost-to-follow-up for at least 24 months.

Methods

Seventy-two eyes of 72 NTG suspect patients who returned to the hospital after at least 24 months of follow-up loss were enrolled in this study between January 2009 and June 2013. The data were collected retrospectively. The incidence of glaucoma was investigated using a comprehensive glaucoma evaluation in lost-to-follow-up NTG suspect patients. The patients were classified into the glaucoma group, who developed glaucoma during the study period, and the glaucoma suspect group, who did not, to analyse the risk factors for glaucoma.

Results

The number of patients who developed glaucoma was 7 (9.7 %) out of the 72 NTG suspect patients who had been mean lost-to-follow-up for 44 months. The rate of progression from suspected to glaucoma was 2.6 %/year. In the glaucoma group, the baseline intraocular pressure (IOP) was 18.43 ± 2.44 mmHg, and the average retinal nerve fiber layer (RNFL) thickness was 78.14 ± 7.60 μm; in the glaucoma suspect group, the baseline IOP was 14.95 ± 2.47 mmHg, and the average RNFL thickness was 92.55 ± 7.65 μm. The study results showed that the glaucoma group had higher baseline IOP and a thinner average RNFL (p = 0.003; p < 0.001). The results of the multivariable logistic regression analysis showed that the risk factors for glaucoma were high baseline IOP (OR = 1.63; p = 0.037) and a thin average RNFL (OR = 0.841; p = 0.004).

Conclusions

The incidence of glaucoma in the lost-to-follow-up NTG suspect patients was 9.7 % for approximately 44 months, at a rate of 2.6 %/year. The risk factors for glaucoma in these patients were high baseline IOP and a thin average RNFL.
Literature
3.
go back to reference Leske MC, Connell AM, Wu SY, Nemesure B, Li X, Schachat A, et al. Incidence of open-angle glaucoma: the Barbados eye studies. The Barbados Eye Studies Group. Arch Ophthalmol. 2001;119:89–95.PubMed Leske MC, Connell AM, Wu SY, Nemesure B, Li X, Schachat A, et al. Incidence of open-angle glaucoma: the Barbados eye studies. The Barbados Eye Studies Group. Arch Ophthalmol. 2001;119:89–95.PubMed
4.
go back to reference Mukesh BN, McCarty CA, Rait JL, Taylor HR. Five-year incidence of open-angle glaucoma: the visual impairment project. Ophthalmology. 2002;109:1047–51.CrossRefPubMed Mukesh BN, McCarty CA, Rait JL, Taylor HR. Five-year incidence of open-angle glaucoma: the visual impairment project. Ophthalmology. 2002;109:1047–51.CrossRefPubMed
5.
go back to reference Dielemans I, Vingerling JR, Wolfs RC, Hofman A, Grobbee DE, de Jong PT. The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology. 1994;101:1851–5.CrossRefPubMed Dielemans I, Vingerling JR, Wolfs RC, Hofman A, Grobbee DE, de Jong PT. The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology. 1994;101:1851–5.CrossRefPubMed
6.
go back to reference Kawase K, Tomidokoro A, Araie M, Iwase A, Yamamoto T, Tajimi Study Group, Japan Glaucoma Society. Ocular and systemic factors related to intraocular pressure in Japanese adults: the Tajimi study. Br J Ophthalmol. 2008;92:1175–9.CrossRefPubMed Kawase K, Tomidokoro A, Araie M, Iwase A, Yamamoto T, Tajimi Study Group, Japan Glaucoma Society. Ocular and systemic factors related to intraocular pressure in Japanese adults: the Tajimi study. Br J Ophthalmol. 2008;92:1175–9.CrossRefPubMed
7.
go back to reference Kim CS, Seong GJ, Lee NH, Song KC, Namil Study Group, Society KG. Prevalence of primary open-angle glaucoma in central South Korea the Namil study. Ophthalmology. 2011;118:1024–30.CrossRefPubMed Kim CS, Seong GJ, Lee NH, Song KC, Namil Study Group, Society KG. Prevalence of primary open-angle glaucoma in central South Korea the Namil study. Ophthalmology. 2011;118:1024–30.CrossRefPubMed
8.
go back to reference Allingham RR, Damji KF, Freedman S, Moroi SE, Rhee DJ. Shields' textbook of glaucoma. 6th ed. Baltimore: Lippincott Wiliams & Wilkins; 2010. chap. 10. Allingham RR, Damji KF, Freedman S, Moroi SE, Rhee DJ. Shields' textbook of glaucoma. 6th ed. Baltimore: Lippincott Wiliams & Wilkins; 2010. chap. 10.
9.
go back to reference Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701–13. discussion 829-30.CrossRefPubMed Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701–13. discussion 829-30.CrossRefPubMed
10.
go back to reference Miglior S, Zeyen T, Pfeiffer N, Cunha-Vaz J, Torri V, Adamsons I, European Glaucoma Prevention Study (EGPS) Group. Results of the European Glaucoma Prevention Study. Ophthalmology. 2005;112:366–75.CrossRefPubMed Miglior S, Zeyen T, Pfeiffer N, Cunha-Vaz J, Torri V, Adamsons I, European Glaucoma Prevention Study (EGPS) Group. Results of the European Glaucoma Prevention Study. Ophthalmology. 2005;112:366–75.CrossRefPubMed
11.
go back to reference Kim YK, Choi HJ, Jeoung JW, Park KH, Kim DM. Five-year incidence of primary open-angle glaucoma and rate of progression in health center-based Korean population: the Gangnam Eye Study. PLoS One. 2014. doi:10.1371/journal.pone.0114058. Kim YK, Choi HJ, Jeoung JW, Park KH, Kim DM. Five-year incidence of primary open-angle glaucoma and rate of progression in health center-based Korean population: the Gangnam Eye Study. PLoS One. 2014. doi:10.​1371/​journal.​pone.​0114058.
12.
13.
go back to reference Kitazawa Y, Horie T, Aoki S, Suzuki M, Nishioka K. Untreated ocular hypertension. A long-term prospective study. Arch Ophthalmol. 1977;95:1180–4.CrossRefPubMed Kitazawa Y, Horie T, Aoki S, Suzuki M, Nishioka K. Untreated ocular hypertension. A long-term prospective study. Arch Ophthalmol. 1977;95:1180–4.CrossRefPubMed
14.
go back to reference Epstein DL, Krug Jr JH, Hertzmark E, Remis LL, Edelstein DJ. A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects. Ophthalmology. 1989;96:1460–7.CrossRefPubMed Epstein DL, Krug Jr JH, Hertzmark E, Remis LL, Edelstein DJ. A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects. Ophthalmology. 1989;96:1460–7.CrossRefPubMed
15.
go back to reference Kass MA, Gordon MO, Hoff MR, Parkinson JM, Kolker AE, Hart Jr WM, et al. Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial. Arch Ophthalmol. 1989;107:1590–8.CrossRefPubMed Kass MA, Gordon MO, Hoff MR, Parkinson JM, Kolker AE, Hart Jr WM, et al. Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial. Arch Ophthalmol. 1989;107:1590–8.CrossRefPubMed
16.
go back to reference Schulzer M, Drance SM, Douglas GR. A comparison of treated and untreated glaucoma suspects. Ophthalmology. 1991;98:301–7.CrossRefPubMed Schulzer M, Drance SM, Douglas GR. A comparison of treated and untreated glaucoma suspects. Ophthalmology. 1991;98:301–7.CrossRefPubMed
18.
go back to reference Bengtsson B, Heijl A. A long-term prospective study of risk factors for glaucomatous visual field loss in patients with ocular hypertension. J Glaucoma. 2005;14:135–8.CrossRefPubMed Bengtsson B, Heijl A. A long-term prospective study of risk factors for glaucomatous visual field loss in patients with ocular hypertension. J Glaucoma. 2005;14:135–8.CrossRefPubMed
19.
go back to reference Kass MA, Hart Jr WM, Gordon M, Miller JP. Risk factors favoring the development of glaucomatous visual field loss in ocular hypertension. Surv Ophthalmol. 1980;25:155–62.CrossRefPubMed Kass MA, Hart Jr WM, Gordon M, Miller JP. Risk factors favoring the development of glaucomatous visual field loss in ocular hypertension. Surv Ophthalmol. 1980;25:155–62.CrossRefPubMed
20.
go back to reference Ponte F, Giuffré G, Giammanco R, Dardanoni G. Risk factors of ocular hypertension and glaucoma. The Casteldaccia Eye Study. Doc Ophthalmol. 1994;85:203–10.CrossRefPubMed Ponte F, Giuffré G, Giammanco R, Dardanoni G. Risk factors of ocular hypertension and glaucoma. The Casteldaccia Eye Study. Doc Ophthalmol. 1994;85:203–10.CrossRefPubMed
21.
go back to reference Kotowski J, Wollstein G, Ishikawa H, Schuman JS. Imaging of the optic nerve and retinal nerve fiber layer: an essential part of glaucoma diagnosis and monitoring. Surv Ophthalmol. 2014;59:458–67.CrossRefPubMed Kotowski J, Wollstein G, Ishikawa H, Schuman JS. Imaging of the optic nerve and retinal nerve fiber layer: an essential part of glaucoma diagnosis and monitoring. Surv Ophthalmol. 2014;59:458–67.CrossRefPubMed
22.
go back to reference Quigley HA, Katz J, Derick RJ, Gilbert D, Sommer A. An evaluation of optic disc and nerve fiber layer examinations in monitoring progression of early glaucoma damage. Ophthalmology. 1992;99:19–28.CrossRefPubMed Quigley HA, Katz J, Derick RJ, Gilbert D, Sommer A. An evaluation of optic disc and nerve fiber layer examinations in monitoring progression of early glaucoma damage. Ophthalmology. 1992;99:19–28.CrossRefPubMed
23.
go back to reference Sommer A, Katz J, Quigley HA, Miller NR, Robin AL, Richter RC, et al. Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch Ophthalmol. 1991;109:77–83.CrossRefPubMed Sommer A, Katz J, Quigley HA, Miller NR, Robin AL, Richter RC, et al. Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch Ophthalmol. 1991;109:77–83.CrossRefPubMed
24.
go back to reference Zeyen TG, Caprioli J. Progression of disc and field damage in early glaucoma. Arch Ophthalmol. 1993;111:62–5.CrossRefPubMed Zeyen TG, Caprioli J. Progression of disc and field damage in early glaucoma. Arch Ophthalmol. 1993;111:62–5.CrossRefPubMed
25.
go back to reference Quigley HA, Addicks EM. Quantitiative studies of retinal nerve fiber layer defects. Arch Ophthalmol. 1982;100:807–14.CrossRefPubMed Quigley HA, Addicks EM. Quantitiative studies of retinal nerve fiber layer defects. Arch Ophthalmol. 1982;100:807–14.CrossRefPubMed
26.
go back to reference Suh JY, Seo HR, Rho SH. Age-related differences of spectral-domain optical coherence tomography data in Koreans. J Korean Ophthalmol Soc. 2013;54:289–95.CrossRef Suh JY, Seo HR, Rho SH. Age-related differences of spectral-domain optical coherence tomography data in Koreans. J Korean Ophthalmol Soc. 2013;54:289–95.CrossRef
27.
go back to reference Hirasawa H, Tomidokoro A, Araie M, Konno S, Saito H, Iwase A, et al. Peripapillary retinal nerve fiber layer thickness determined by spectral-domain optical coherence tomography in ophthalmologically normal eyes. Arch Ophthalmol. 2010;128:1420–6.CrossRefPubMed Hirasawa H, Tomidokoro A, Araie M, Konno S, Saito H, Iwase A, et al. Peripapillary retinal nerve fiber layer thickness determined by spectral-domain optical coherence tomography in ophthalmologically normal eyes. Arch Ophthalmol. 2010;128:1420–6.CrossRefPubMed
28.
go back to reference Alasil T, Wang K, Keane PA, Lee H, Baniasadi N, de Boer JF, et al. Analysis of normal retinal nerve fiber layer thickness by age, sex, and race using spectral domain optical coherence tomography. J Glaucoma. 2013;22:532–41.CrossRefPubMed Alasil T, Wang K, Keane PA, Lee H, Baniasadi N, de Boer JF, et al. Analysis of normal retinal nerve fiber layer thickness by age, sex, and race using spectral domain optical coherence tomography. J Glaucoma. 2013;22:532–41.CrossRefPubMed
Metadata
Title
Incidence of and risk factors for glaucoma in lost-to-follow-up normal-tension glaucoma suspect patients
Authors
Jong Hoon Lim
Jun Sang Park
So Yeon Lee
Young Jae Hong
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2016
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-016-0245-x

Other articles of this Issue 1/2016

BMC Ophthalmology 1/2016 Go to the issue